anonymous
Guest
anonymous
Guest
I disagree.
I think you are being hard on our fraternity///.... I mean company.
Yes, we screwed up what could have been a simple launch of an epilepsy product by tying it to an expensive fit-bit watch strategy.
And yes we created a generic vs brand offering that the docs and pharmacies could not understand. And then we threw out our patient centric mantra and took a huge price increase.
And I suppose we also brought in and promoted only the best friends of our assigned Prince (as long as they dressed correctly).
But other than that, I think your criticism is unjust...
I think you are being hard on our fraternity///.... I mean company.
Yes, we screwed up what could have been a simple launch of an epilepsy product by tying it to an expensive fit-bit watch strategy.
And yes we created a generic vs brand offering that the docs and pharmacies could not understand. And then we threw out our patient centric mantra and took a huge price increase.
And I suppose we also brought in and promoted only the best friends of our assigned Prince (as long as they dressed correctly).
But other than that, I think your criticism is unjust...